InvestSMART

Truscreen Group Limited (ASX:TRU)

ALERT: Price-sensitive ASX Announcement for TRU
Current share price for TRU : $0.013 -0.002 (-13.33%)+
Announcement
Release
26 Feb 2026 8:38AM
Price at Release
$0.015
Full Release
download
Summary
Truscreen Group Limited, trading as TRU on NZX/ASX, provided an update on its revenue and earnings guidance for the fiscal year ending 31 March 2026 (FY2026). The company anticipates product sales revenue of approximately NZ$2.4 million, a 41% increase from FY2025 but below the previous guidance of NZ$2.8 million. This shortfall is due to delayed payments from Uzbekistan and a postponed order from Zimbabwe. Total revenue is expected to reach NZ$2.7 million, a 28% increase from FY2025. The company predicts a net loss of around NZ$2.2 million, consistent with FY2025, due to increased market access expenses and a smaller tax refund from reduced R&D spending. Investments during FY2026 focused on expanding distribution in Uzbekistan, India, Indonesia, and select African markets to boost product adoption and profitability. The company highlighted a positive reception of its AI-enabled TruScreen technology following a study involving 15,000 patients by the Chinese Obstetricians and Gynaecologists Association. The board believes in keeping the market updated with detailed quantitative guidance and drivers to fulfill its disclosure obligations.
Key Points
  • FY2026 product sales revenue expected to be NZ$2.4 million
  • Total revenue for FY2026 expected to be approximately NZ$2.7 million
  • Expected net loss of ~NZ$2.2 million for FY2026
  • Investment in expanding distributor network in Uzbekistan, India, Indonesia, and African markets
  • Recent clinical study results increased interest in TruScreen technology
  • Reduced Australian R&D tax refund due to lower expenditure
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.